Endovascular treatment of diabetic peripheral arterial disease in older and oldest old patients: a retrospective study

Cristina Gatti, Sara Cecchini, Paolo Fabbietti, Fabio Romagnoli, Stefano Ricci

Research output: Contribution to journalArticle

Abstract

Background: Peripheral arterial disease (PAD) is frequent among older diabetic patients, but the evidence about endovascular revascularization is very limited. Method: We retrospectively analyzed data collected from 120 diabetic patients consecutively admitted to a Diabetic Foot Clinic, including 64 patients aged 65–79 years and 56 patients aged 80 or more. Results: Percutaneous transluminal angioplasty (PTA) was followed by technical success in 82.5% of older patients and 62.5% of oldest old ones (p = 0.05). No significant difference was observed in regards to complete re-epithelization (76.6 vs 76.8%, p = 0.820), recurrent stenosis (26.6 vs 19.6%, p = 0.371), intra- or post-procedure complications (21.9 vs 10.7%, p = 0.102), and amputations (12.5 vs 5.4%, p = 0.176). Discussion: Our findings suggest that older and oldest old patients with diabetic foot and critical ischemia could be effectively and safely treated with PTA.

Original languageEnglish
Pages (from-to)1-3
Number of pages3
JournalAging clinical and experimental research
DOIs
Publication statusE-pub ahead of print - Jun 3 2017

Fingerprint

Peripheral Arterial Disease
Retrospective Studies
Diabetic Foot
Angioplasty
Therapeutics
Amputation
Pathologic Constriction
Ischemia

Keywords

  • Amputations
  • Complete re-epithelization
  • Endovascular revascularization
  • Percutaneous transluminal angioplasty
  • Peripheral arterial disease
  • Recurrent stenosis

ASJC Scopus subject areas

  • Ageing
  • Geriatrics and Gerontology

Cite this

@article{2efa0261edef4e57a2b7c98490529525,
title = "Endovascular treatment of diabetic peripheral arterial disease in older and oldest old patients: a retrospective study",
abstract = "Background: Peripheral arterial disease (PAD) is frequent among older diabetic patients, but the evidence about endovascular revascularization is very limited. Method: We retrospectively analyzed data collected from 120 diabetic patients consecutively admitted to a Diabetic Foot Clinic, including 64 patients aged 65–79 years and 56 patients aged 80 or more. Results: Percutaneous transluminal angioplasty (PTA) was followed by technical success in 82.5{\%} of older patients and 62.5{\%} of oldest old ones (p = 0.05). No significant difference was observed in regards to complete re-epithelization (76.6 vs 76.8{\%}, p = 0.820), recurrent stenosis (26.6 vs 19.6{\%}, p = 0.371), intra- or post-procedure complications (21.9 vs 10.7{\%}, p = 0.102), and amputations (12.5 vs 5.4{\%}, p = 0.176). Discussion: Our findings suggest that older and oldest old patients with diabetic foot and critical ischemia could be effectively and safely treated with PTA.",
keywords = "Amputations, Complete re-epithelization, Endovascular revascularization, Percutaneous transluminal angioplasty, Peripheral arterial disease, Recurrent stenosis",
author = "Cristina Gatti and Sara Cecchini and Paolo Fabbietti and Fabio Romagnoli and Stefano Ricci",
year = "2017",
month = "6",
day = "3",
doi = "10.1007/s40520-017-0760-5",
language = "English",
pages = "1--3",
journal = "Aging clinical and experimental research",
issn = "1594-0667",
publisher = "Springer International Publishing AG",

}

TY - JOUR

T1 - Endovascular treatment of diabetic peripheral arterial disease in older and oldest old patients

T2 - a retrospective study

AU - Gatti, Cristina

AU - Cecchini, Sara

AU - Fabbietti, Paolo

AU - Romagnoli, Fabio

AU - Ricci, Stefano

PY - 2017/6/3

Y1 - 2017/6/3

N2 - Background: Peripheral arterial disease (PAD) is frequent among older diabetic patients, but the evidence about endovascular revascularization is very limited. Method: We retrospectively analyzed data collected from 120 diabetic patients consecutively admitted to a Diabetic Foot Clinic, including 64 patients aged 65–79 years and 56 patients aged 80 or more. Results: Percutaneous transluminal angioplasty (PTA) was followed by technical success in 82.5% of older patients and 62.5% of oldest old ones (p = 0.05). No significant difference was observed in regards to complete re-epithelization (76.6 vs 76.8%, p = 0.820), recurrent stenosis (26.6 vs 19.6%, p = 0.371), intra- or post-procedure complications (21.9 vs 10.7%, p = 0.102), and amputations (12.5 vs 5.4%, p = 0.176). Discussion: Our findings suggest that older and oldest old patients with diabetic foot and critical ischemia could be effectively and safely treated with PTA.

AB - Background: Peripheral arterial disease (PAD) is frequent among older diabetic patients, but the evidence about endovascular revascularization is very limited. Method: We retrospectively analyzed data collected from 120 diabetic patients consecutively admitted to a Diabetic Foot Clinic, including 64 patients aged 65–79 years and 56 patients aged 80 or more. Results: Percutaneous transluminal angioplasty (PTA) was followed by technical success in 82.5% of older patients and 62.5% of oldest old ones (p = 0.05). No significant difference was observed in regards to complete re-epithelization (76.6 vs 76.8%, p = 0.820), recurrent stenosis (26.6 vs 19.6%, p = 0.371), intra- or post-procedure complications (21.9 vs 10.7%, p = 0.102), and amputations (12.5 vs 5.4%, p = 0.176). Discussion: Our findings suggest that older and oldest old patients with diabetic foot and critical ischemia could be effectively and safely treated with PTA.

KW - Amputations

KW - Complete re-epithelization

KW - Endovascular revascularization

KW - Percutaneous transluminal angioplasty

KW - Peripheral arterial disease

KW - Recurrent stenosis

UR - http://www.scopus.com/inward/record.url?scp=85020219254&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85020219254&partnerID=8YFLogxK

U2 - 10.1007/s40520-017-0760-5

DO - 10.1007/s40520-017-0760-5

M3 - Article

AN - SCOPUS:85020219254

SP - 1

EP - 3

JO - Aging clinical and experimental research

JF - Aging clinical and experimental research

SN - 1594-0667

ER -